you are here: HomeNewsLupin
lupin
Jump to
2788 Results Found
  • Lupin launches Posaconazole delayed-release tablets; share dips 2% Feb 17, 2021 11:44 AM IST

    Lupin launches Posaconazole delayed-release tablets; share dips 2%

    Posaconazole had estimated annual sales of USD 186 million in the US

  • Buy Lupin; target of Rs 1350: Sharekhan Feb 08, 2021 04:07 PM IST

    Buy Lupin; target of Rs 1350: Sharekhan

    Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated January 29, 2021.

  • Buy Lupin; target of Rs 1287: Prabhudas Lilladher Feb 05, 2021 08:57 PM IST

    Buy Lupin; target of Rs 1287: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1287 in its research report dated January 29, 2021.

  • Buy Lupin; target of Rs 1165: ICICI Direct Feb 05, 2021 07:14 PM IST

    Buy Lupin; target of Rs 1165: ICICI Direct

    ICICI Direct is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated January 29, 2021.

  • Buy Lupin; target of Rs 1180: Motilal Oswal Feb 03, 2021 08:47 PM IST

    Buy Lupin; target of Rs 1180: Motilal Oswal

    Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated January 30, 2021.

  • Lupin: New launches and market share gains are likely to override pricing erosion Feb 03, 2021 09:57 AM IST

    Lupin: New launches and market share gains are likely to override pricing erosion

    New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin

  • Buy Lupin; target of Rs 1350: Sharekhan Feb 01, 2021 06:38 PM IST

    Buy Lupin; target of Rs 1350: Sharekhan

    Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated January 25, 2021.

  • Lupin Standalone December 2020 Net Sales at Rs 2,802.47 crore, up 3.19% Y-o-Y Jan 29, 2021 09:22 AM IST

    Lupin Standalone December 2020 Net Sales at Rs 2,802.47 crore, up 3.19% Y-o-Y

  • Lupin Consolidated December 2020 Net Sales at Rs 4,017.36 crore, up 6.58% Y-o-Y Jan 29, 2021 09:22 AM IST

    Lupin Consolidated December 2020 Net Sales at Rs 4,017.36 crore, up 6.58% Y-o-Y

  • Lupin share price gains 2% on USFDA approval Jan 25, 2021 01:57 PM IST

    Lupin share price gains 2% on USFDA approval

    The share touched its 52-week high Rs 1,121.85 and 52-week low Rs 505.00 on 18 September, 2020 and 13 March, 2020, respectively.

  • Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets Jan 25, 2021 01:54 PM IST

    Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets

    The product is a generic version of Genzyme Corporation's Renvela tablets in the same strength, Lupin added.

  • Netflix's 'Lupin' marks rise of international TV content Jan 24, 2021 06:13 PM IST

    Netflix's 'Lupin' marks rise of international TV content

    The emergence of international platforms, mainly Netflix but also more recently Amazon and Disney+, has played a leading role in driving this appetite for content.

  • Lupin review: Netflix starts the year with a fabulous new show about a gentleman thief Jan 09, 2021 09:07 AM IST

    Lupin review: Netflix starts the year with a fabulous new show about a gentleman thief

    Netflix creates Lupin magic in the smile of Omar Sy, and I think no one better could have been cast. The lone wolf of the comic book and anime is shown to be a dad here with the delightful Ludvine Sagnier playing his ex-wife.

  • Lupin gets USFDA nod for generic diabetes drug Jan 07, 2021 05:26 PM IST

    Lupin gets USFDA nod for generic diabetes drug

    The product will be manufactured at Lupin’s Nagpur-based manufacturing facility.

  • Lupin launches Mycophenolate Mofetil tablets in US Dec 29, 2020 03:31 PM IST

    Lupin launches Mycophenolate Mofetil tablets in US

    The newly launched product is the generic equivalent of CellCept tablets of Roche Palo Alto LLC.

  • Lupin shares rise 3% on USFDA nod Dec 22, 2020 09:47 AM IST

    Lupin shares rise 3% on USFDA nod

    The share touched its 52-week high of Rs 1,121.85 and its 52-week low of Rs 505.00 on 18 September 2020 and 13 March 2020, respectively.

  • Buy Lupin; target of Rs 1212: Prabhudas Lilladher Nov 12, 2020 03:25 PM IST

    Buy Lupin; target of Rs 1212: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1212 in its research report dated November 06, 2020.

  • Buy Lupin; target of Rs 1120: HDFC Securities Nov 09, 2020 04:23 PM IST

    Buy Lupin; target of Rs 1120: HDFC Securities

    HDFC Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1120 in its research report dated November 06, 2020.

  • USFDA issues 13 observations after inspection of Lupin arm's Somerset facility Nov 09, 2020 11:13 AM IST

    USFDA issues 13 observations after inspection of Lupin arm's Somerset facility

    Lupin said it does not believe that this will have an impact on disruption of supplies or the existing revenues from operations of this facility.

  • Cipla: Covid opportunity and traction for Albuterol strong positives; accumulate Nov 09, 2020 09:16 AM IST

    Cipla: Covid opportunity and traction for Albuterol strong positives; accumulate

    Cipla continues to be a significant pharma play during the pandemic because of its strong respiratory and a growing Covid portfolio

  • Cipla asks its IT team to be on alert after cyber attacks on major pharma firms Nov 08, 2020 11:12 PM IST

    Cipla asks its IT team to be on alert after cyber attacks on major pharma firms

    Cipla CFO Kedar Upadhye has asked his IT team to be as paranoid as possible and take the help of experts, and continue to track some hostile activities like conversations on the dark web, and multiple other things that one can do

  • Hold Lupin; target of Rs 985: ICICI Direct Nov 07, 2020 11:44 AM IST

    Hold Lupin; target of Rs 985: ICICI Direct

    ICICI Direct recommended hold rating on Lupin with a target price of Rs 985 in its research report dated November 06, 2020.

  • Business Insight | After Dr Reddy’s, Lupin reports cybersecurity attack Nov 06, 2020 09:14 PM IST

    Business Insight | After Dr Reddy’s, Lupin reports cybersecurity attack

    Just before the incident, Lupin had announced its September quarter results and Dr Reddy's had received approval for clinical trials of Russia’s Sputnik V vaccine

  • Lupin: Covid opportunity strengthens US business Nov 06, 2020 09:41 AM IST

    Lupin: Covid opportunity strengthens US business

    The possibility of positive developments on the product pipeline front and restructuring initiatives can accelerate earnings growth for Lupin

  • Lupin expects 18.5% EBITDA margins in the second half of FY21 led by rebound of US, India businesses Nov 05, 2020 10:48 PM IST

    Lupin expects 18.5% EBITDA margins in the second half of FY21 led by rebound of US, India businesses

    Lupin said in order to achieve 18.5 percent EBITDA, it would also keep its expenses tight by restricting employee costs at 18 percent of sales

Sections